News

SC Johnson supports Gulf oil spill relief efforts

BY Allison Cerra

RACINE, Wis. SC Johnson is offering its help in the oil spill cleanup efforts in the Gulf of Mexico.

In an effort to quickly provide support to the large number of relief agencies, volunteers, government and contractor groups, SC Johnson is donating approximately 5,000 product units of its trusted pest repellent brand Off!

Gifts in Kind International, an international nonprofit organization and one of the country’s largest charities, will distribute the pest control products on bhelf of SC Johnson over the next few weeks.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Target gets set to open in East Harlem

BY DSN STAFF

MINNEAPOLIS Target announced that it will open its first store on the island of Manhattan in East Harlem on July 25.

According to the company, the store features more space devoted to fresh food, everyday essentials and home basics geared for apartment living. The store is easily accessible with a pedestrian bridge linking mass transit to the store on the second floor of the East River Plaza. A parking deck is also available.

The retailer also said it has tailored the store’s merchandise to reflect the culture of the community. As such, Target said the Harlem store will offer Spanish-language books and movies, multicultural dools and Gospel and Latin music.

 

As with all Target stores, the new general merchandise store will offer everyday essentials, household products, electronics, clothing and seasonal items. And, it will feature Target’s new expanded food layout offering fresh packaged produce, meats and baked goods, the company reported.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA approves expanded use of Infergen

BY Alaric DeArment

WARRENDALE, Pa. The Food and Drug Administration has approved a new use for a hepatitis C drug made by Three Rivers Pharmaceuticals, the drug maker said Friday.

The FDA approved Three Rivers’ Infergen (interferon alfacon-1) combined with ribavirin for daily treatment of hepatitis C in patients who have failed to respond to pegylated interferon combined with ribavirin.

The approval is based on a late-stage clinical study showing that the combination of Infergen and ribavirin rendered the virus undetectable, also known as sustained virological response.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES